These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23290851)

  • 1. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
    Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008].
    Chang S; Dai M; Ren JS; Chen YH; Guo LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Apr; 33(4):391-4. PubMed ID: 22781412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008].
    Zhang ML; Huang ZZ; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1049-51. PubMed ID: 23290849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimates and prediction on incidence, mortality and prevalence of brain and neurologic tumors in China, 2008].
    Ke JZ; Zheng Y; Lu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1060-3. PubMed ID: 23290852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation and prediction of incidence, mortality and prevalence on liver cancer, in 2008, China].
    Li Q; DU J; Guan P; DU J; Qu CF; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jun; 33(6):554-7. PubMed ID: 22883258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation and prediction for incidence, mortality and prevalence of common gastrointestinal tract cancers in China, in 2008].
    Ren JS; Li Q; Guan P; Dai M; Yang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1052-5. PubMed ID: 23290850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation and prediction on cancer related incidence and mortality in China, 2008].
    Dai M; Ren JS; Li N; Li Q; Yang L; Chen YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jan; 33(1):57-61. PubMed ID: 22575112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012.
    Ondrusova M; Mrozova L; Ondrus D; Mrinakova B
    Neoplasma; 2013; 60(4):446-51. PubMed ID: 23581418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disease burden of prostate cancer among men in China, from 1990 to 2013].
    Qi JL; Wang LJ; Zhou MG; Liu YN; Liu JM; Liu SW; Zeng XY; Yin P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):778-82. PubMed ID: 27346101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
    Gilliland F; Becker TM; Smith A; Key CR; Samet JM
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
    Coldman AJ; Phillips N; Pickles TA
    CMAJ; 2003 Jan; 168(1):31-5. PubMed ID: 12515782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].
    Wei KR; Chen WQ; Zhang SW; Zheng RS; Wang YN; Liang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):445-51. PubMed ID: 22932112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].
    Bernal M; Romero FJ; Souza DL; Gómez-Bernal FJ; Gómez-Bernal GJ
    Actas Urol Esp; 2011 Sep; 35(8):470-4. PubMed ID: 21621302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trend of incidence and mortality on thyroid cancer in China during 2003 - 2007].
    Liu YQ; Zhang SQ; Chen WQ; Chen LL; Zhang SW; Zhang XD; Zheng RS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1044-8. PubMed ID: 23290848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer in American Indians, New Mexico, 1969 to 1994.
    Gilliland FD; Key CR
    J Urol; 1998 Mar; 159(3):893-7; discussion 897-8. PubMed ID: 9474177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer in Denmark 1978-2009--trends in incidence and mortality.
    Outzen M; Brasso K; Martinussen N; Christensen J; Tjønneland A; Friis S; Olsen A
    Acta Oncol; 2013 May; 52(4):831-6. PubMed ID: 22809166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on cancer incidence through the cancer registry program in 11 cities and counties, China].
    Lei T; Mao WM; Yang HJ; Chen XZ; Lei TH; Wang XH; Ying Q; Chen WQ; Zhang SW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1165-70. PubMed ID: 20193588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.